InMed Pharmaceuticals Inc. Common Shares
Market Cap
9.1M
Short interest (Jul 15)
2.2%
Net Short (Jul 27 ): -0.1%
Borrow Fee
261.61%
↑ 91.5%
Available Shares
500K
↓ 69.2%
Price Chart
Company Overview
InMed Pharmaceuticals Inc is a pharmaceutical company developing a pipeline of disease-modifying small molecule drug candidates targeting CB1 and CB2 receptors. The company's pipeline consists of three separate programs in the treatment of Alzheimer's, ocular and dermatological indications.
Company Info
Market Data
Short Interest
Recent Changes
Quick Actions
Investment Risk
This is not financial advice. All investments carry risk. Do your own research before making investment decisions.